Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids

Veterinary Journal

Volumn 165, Issue 2, 2003, Pages 104-118

  Shojaee Aliabadi, F ^a,d   Ali, Badrelin H ^b   Landoni, M F ^c   Lees, P ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^d Food Quality Control Laboratory   (Iran)

Author keywords

Camel; Danofloxacin; Exudate; Pharmacokinetics; PK PD modelling; Serum; Transudate

Indexed keywords

DANOFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BODY FLUID; CAMEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG TISSUE LEVEL; ESCHERICHIA COLI O157; EXUDATE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOLOGICAL PARAMETERS; SERUM; ABSORPTION; ANIMAL; CLINICAL TRIAL; HALF LIFE TIME; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION;

BACTERIA (MICROORGANISMS); CAMELIDAE; ESCHERICHIA COLI; ESCHERICHIA COLI 0157;

ABSORPTION; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CAMELS; FEMALE; FLUOROQUINOLONES; HALF-LIFE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MALE;

EID: 0347706219     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-0233(02)00258-7     Document Type: Article

References (43)

1. Apley M.D. Upson D.W. Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia American Journal of Veterinary Research 54 1993 937-943
2. Apley M.D. Upson D.W. Regional danofloxacin lung tissue concentrations and their relationship to regional pulmonary blood flow in consolidated and non-consolidated bovine lung American Journal of Veterinary Research 54 1993 944-951
3. Appelbaum P.C. Hunter P.A. The fluoroquinolone antibacterials: past, present and future perspectives International Journal of Antimicrobial Agents 16 2000 5-15
4. Atef M. El-Gendi Aziza Amer M.M. AbdEl-Aty A.M. Some pharmacokinetic data for danofloxacin in healthy goats Veterinary Research Communications 25 2001 367-377
5. Bergan T. Pharmacokinetics of tissue penetration of antibiotics Review of Infectious Diseases 3 1981 45-66
6. Blaser J. Stone B.B. Groner M.C. Zinner S.H. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bacterial activity and emergence of resistance Antimicrobial Agents Chemotherapy 31 1987 1054-1060
7. Brown S.A. Fluoroquinolones in animal health Journal of Veterinary Pharmacology and Therapeutics 19 1996 1-14
8. Clarke C.R. Tissue-chamber modelling systems-applications in veterinary medicine Journal of Veterinary Pharmacology and Therapeutics 12 1989 349-368
9. Cooper A.C. Fuller J.R. Fuller M.K. Whittlestone P. Wise D.R. In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance Research in Veterinary Science 54 1993 329-334
10. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men Clinical Infectious Diseases 26 1998 1-12
11. Dalhoff A. Ullman U. Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models European Journal of Microbiological Infectious Diseases 9 1990 479-487
12. Drusano G.L. Johnson D.E. Rosen M. Standiford H. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis Antimicrobial Agents and Chemotherapy 37 1993 483-490
13. Dudley M.N. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones American Journal of Medicine 91 Suppl. 6A 1991 455-505
14. Forrest A. Nix D.E. Ballo C.H. Goss T.G. Birmingham M.C. Schentag J.J. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients Antimicrobial Agents and Chemotherapy 37 1993 1073-1081
15. Friis C. Penetration of danofloxacin into the respiratory tract tissues and secretion in calves American Journal of Veterinary Research 54 1993 1122-1127
16. Giles, C. J. (1991). Danofloxacin: a new antimicrobial for therapy of infectious respiratory diseases in cattle and swine. Proceedings of the Royal Veterinary College/Pfizer Symposium on Respiratory Disease in Cattle and Pigs. Hawkshead Campus: Royal Veterinary College, pp. 87-96
17. Giles C.J. Magonigle R.A. Grimshaw W.T.R. Tanner A.C. Risk J.E. Lynch M.J. Rice J.R. Clinical pharmacokinetics of administered danofloxacin in cattle Journal of Veterinary Pharmacology and Therapeutics 14 1991 400-410
18. Grimshaw W.T.R. Giles C.J. Cooper A.C. Shanks D.J. The efficacy of danofloxacin in the therapy of pneumonia associated with Pasteurella species in housed calves Deutsche Tieraztliche Wochenschrift 97 1990 529-532
19. Higgins A.J. Lees P. Wright J.A. Tissue-cage model for the collection of inflammtory exudate in ponies Research in Veterinary Science 36 1984 284-289
20. Higgins A.J. Lees P. Sedgwick A.D. Development of equine models of inflammation Veterinary Record 120 1987 529-535
21. Hyatt J.M. Nix D.E. Schentag J.J. Pharmacokinetics and pharmacodynamics of ciprofloxacin against similar MIC strains of S. pneumoniae, S. aureus and P. aeruginosa using kill curve methodology Antimicrobial Agents and Chemotherapy 38 1994 2730-2737
22. Hyatt J.M. McKinnon P.S. Zimmer G.S. Schentag J.J. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome, focus on antibacterial agents Clinical Pharmacological Concepts 28 1995 143-160
23. Lees P. Shojaee Aliabadi F. Rationalising dosage schedules of antimicrobial drugs: a pharmacological perspective Journal of Medical Microbiology 49 2000 943-945
24. Lees P. Shojaee Aliabadi F. Rational dosing of antimicrobial drugs: animals versus humans International Journal of Antimicrobial Agents 19 2002 269-284
25. Leggett J.E. Frantin R. Ebert S. Totsuka K. Vogelman B. Calame W. Mattie H. Craig W.A. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh infection models Journal of Infectious Diseases 159 1989 281-290
26. Leggett J.E. Ebert S. Fantin B. Craig W.A. Comparative dose-effect relationships at several dosing intervals for β-lactam, aminoglycoside and quinolone antibiotics against Gram-negative bacilli in murine thigh-infection and pneumonitis models Scandinavian Journal of Infectious Diseases 74 1991 179-184
27. Lindecrona R.H. Friis C. Jensen N.E. The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in vitro pharmacodynamic model Research in Veterinary Science 67 1999 93-97
28. Lindecrona R.H. FriIs C. Nielsen J.P. Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs Research in Veterinary Science 68 2000 211-216
29. McGuirk P.R. Jefson M.R. Mann D.D. Elliott N.C. Chang P. Cisek K. Cornell E.P. Gootz T.D. Haskell S.I. Hindahl H.L. Lafleur L.J. Rosenfeld M.J. Smyryock R. Silvia A.M. Weber F.H. Synthesis and structure-activity relationship of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine Journal of Medicine and Chemotherapy 35 1992 611-621
30. McKellar Q.A. Gibson I.F. McCormack R.Z. Pharmacokinetics and tissue disposition of danofloxacin in sheep Biopharmaceutics and Drug Disposition 19 1998 123-129
31. Nicolau D.P. Quintiliani R. Nightingale C.H. Antibiotic kinetics and dynamics for the clinician Antimicrobial Therapy, Medical Clinics of North America 79 1995a 477-495
32. Nicolau D.P. Freeman C.D. Belliveau P.P. Nightingale C.H. Ross J.W. Quintilliani R. Once daily aminoglycoside program: Experience with a once-daily aminoglycosides program administered 2184 adult patients Antimicrobial Agents and Chemotherapy 39 1995b 650-655
33. Sarasola P. Lees P. Shojaee Aliabadi F. McKellar Q.A. Donachie W. Marr K.A. Sunderland S.J. Rowan T.G. Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica Antimicrobial Agents and Chemotherapy 46 2002 3013-3019
34. Schaaf T.K. Danofloxacin. a new fluoroquinolone for veterinary medicine Proceedings of The Royal Veterinary College/Pfizer Symposium on Respiratory Disease in Cattle and Pigs 1991 75-86 Royal Veterinary College Hawkshead Campus
35. Shem-Tov M. Ziv G. Glickman A. Saran A. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of ewes Veterinary Research 28 1997 571-579
36. Shem-Tov M. Rav-Hon O. Ziv G. Lavi E. Glickman A. Saran A. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows Journal of Veterinary Pharmacology and Therapeutics 21 1998 209-213
37. Shojaee aliabadi, F. (1997). Danofloxacin Pharmacodynamic and Pharmacokinetic Inter-Relationships in Ruminant Species. PhD Thesis, University of London
38. Shojaee Aliabadi F. Lees P. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation International Journal of Antimicrobial Agents 14 2000 307-313
39. Shojaee Aliabadi F. Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration American Journal of Veterinary Research 62 2001 1979-1989
40. Shojaee aliabadi, F., & Lees, P. (2002a). Pharmacokinetics, pharmacodynamics and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, in press
41. Shojaee Aliabadi F. Lees P. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate, and transudate Journal of Veterinary Pharmacology and Therapeutics 25 2002b 161-174
42. Vogelman B. Gudmundsson S. Leggett J. Turnidge J. Ebert S. Craig W.A. Correlation of antibacterial pharmacokinetic parameters with therapeutic efficacy in animal models Journal of Infectious Diseases 158 1988 831-847
43. White D.G. Johnson C.K. Cracknell V. Comparison of danofloxacin with baquiloprim/sulphadimidine for the treatment of experimentally induced Escherichia coli diarrhoea in calves The Veterinary Record 143 1998 273-276